“The outlook revision reflects a weakened financial profile, including weaker cash flow and coverage of maximum annual debt service over the past 18 months after allocating the net benefit of the California provider fee program to the year in which the funds were generated, combined with declines in unrestricted cash and investments to levels that are light for the current rating,” said S&P credit analyst Martin Arrick.
More articles on healthcare finance:
Navicure launches analytics tool for insight into revenue cycle performance
FAIR Health database tops 20 billion in private insurance claims
Ascension, Towerbrook Capital forge equity partnership in HIT subsidiary: 3 facts
